Xtx Topco LTD Organogenesis Holdings Inc. Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.61 - $4.49 $93,819 - $161,397	-35,946 Reduced 45.2%	43,584 $123,000
Q4 2023 Feb 13, 2024	BUY	$1.97 - $4.21 $156,674 - $334,821	79,530 New	79,530 $325,000
Q2 2023 Aug 14, 2023	SELL	$1.9 - $4.3 $373,346 - $844,941	-196,498 Reduced 66.59%	98,602 $327,000
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $147,348 - $228,428	77,962 Added 35.9%	295,100 $628,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $3.43 $158,055 - $218,600	63,732 Added 41.54%	217,138 $584,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $481,694 - $986,400	153,406 New	153,406 $497,000
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $83,433 - $143,456	-17,602 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $113,884 - $168,451	17,602 New	17,602 $134,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.